In a study by Meijer et al. [153], Elevated PSAP mRNA was significantly associated with shorter progression-free (PFS) survival in patients with estrogen receptor (ER)-positive breast cancer treated with tamoxifen. This evidence concerns the gene ESR1 and breast carcinoma.